OPTIEUM BIOTECHNOLOGIES

optieum-biotechnologies-logo

Optieum Biotechnologies Inc. is a pre-clinical stage biotechnology company committed to developing innovative scFv antibody-based therapies for the treatment of patients with cancers. Their proprietary platform technology, Eumbody System™, enables to develop and detect a scFv-based product candidates that specifically bind to, and modulate to optimize the immune-cell function for oncology targets. We are committed to helping patients with severe diseases by bringing life-changing therapies to the patients in need.

#SimilarOrganizations #Financial #Website #More

OPTIEUM BIOTECHNOLOGIES

Industry:
Biotechnology

Founded:
2020-03-01

Address:
Matsuyama-shi, Ehime, Japan

Country:
Japan

Website Url:
http://www.optieumbio.com

Total Employee:
1+

Status:
Active

Total Funding:
290 M JPY

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins


Similar Organizations

bright-peak-therapeutics-logo

Bright Peak Therapeutics

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

mabspace-biosciences-logo

MabSpace Biosciences

MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.

vera-therapeutics-logo

Vera Therapeutics

Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.

Investors List

real-tech-fund_image

Real Tech Japan

Real Tech Japan investment in Seed Round - Optieum Biotechnologies

iyogin-capital_image

Iyogin Capital

Iyogin Capital investment in Seed Round - Optieum Biotechnologies

anri_image

ANRI

ANRI investment in Seed Round - Optieum Biotechnologies

Official Site Inspections

http://www.optieumbio.com

  • Host name: www54.onamae.ne.jp
  • IP address: 150.95.219.149
  • Location: Japan
  • Latitude: 35.69
  • Longitude: 139.69
  • Timezone: Asia/Tokyo

Loading ...

More informations about "Optieum Biotechnologies"

OPTIEUM BIOTECHNOLOGIES

Optieum Biotechnologies and National Cancer Center Japan Signed Joint Research Agreement on Solid Tumor Targeting CAR-T Cell ProgramsSee details»

Optieum Biotechnologies - Crunchbase Company Profile & Funding

Optieum Biotechnologies Inc. is a pre-clinical stage biotechnology company committed to developing innovative scFv antibody-based therapies for the treatment of patients with cancers.See details»

Announcement of Grant Award from NEDO - OPTIEUM BIO

We are pleased to announce that Optieum Biotechnologies Inc. has been awarded “NEDO STS” grant from New Energy and Industrial Technology Development Organization (NEDO). This …See details»

Optieum Biotechnologies Inc. | LinkedIn

Optieum Biotechnologies Inc. Biotechnology Research Toon-shi, Ehime 250 followers Generation of optimal CAR constructs for cell therapy empowermentSee details»

Announcement of Grant Award from NEDO - optieumbio.com

Jan 27, 2022 www.optieumbio.com Announcement of Grant Award from NEDO We are pleased to announce that Optieum Biotechnologies Inc. has been awarded “NEDO STS” grant from …See details»

Optieum Biotechnologies - PitchBook

Optieum Biotechnologies General Information Description. Developer of antibody-based therapies designed to help in the treatment of patients with cancers. The company's therapies facilitate …See details»

Optieum Biotechnologies - F6S

Optium Biotechnologies Co., Ltd. is a biopharmaceutical company founded in 2020. Our founding scientist group, Dr. Toshimoto Ochi, Professor Katsuto Takenaka, Professor Masakatsu Yamashita of Ehime University, and President Masataka Yasukawa of Ehime University of Medical Technology, has applied genetic modification technology to develop a highly effective …See details»

Optieum Biotechnologies - VentureRadar

Website: https://optieumbio.com. Develops innovative scFv antibody-based therapies for cancer treatment through proprietary Eumbody System™, enhancing immune-cell functionality for …See details»

Optieum Biotechnologies - Products, Competitors, Financials, …

Optieum Biotechnologies is a biopharmaceutical company focused on the development of novel technologies for the creation of optimized Chimeric Antigen Receptor (CAR) constructs. Use …See details»

Optieum Biotechnologies - CoBee Company Profile & Funding …

Optieum Biotechnologies Inc. is a pre-clinical stage biotechnology company committed to developing innovative scFv antibody-based therapies for the treatment of patients with …See details»

Seed Round - Optieum Biotechnologies - 2021-09-30 - Crunchbase

Optieum Biotechnologies raised $2601684 on 2021-09-30 in Seed Round. Start Free TrialSee details»

オプティアム・バイオテクノロジーズ株式会社の会社情報と資金 …

【NIKKEI COMPASS】オプティアム・バイオテクノロジーズ株式会社は、がんをはじめとした難治性疾患に対する新たな抗体医薬品の開発を目指す愛媛 ...See details»

Optieum Biotechnologies Inc. - Jobs in Japan - CareerCross

Optieum Biotechnologies Inc. is a pre-clinical stage biotechnology company committed to developing innovative scFv antibody-based therapies for the treatment of patients with …See details»

EN – OPTIEUM BIOTECHNOLOGIES

Mar 19, 2021 Generate the optimized scFvs to yield CAR-T cells with robust anti-tumor effectSee details»

オプティアム・バイオテクノロジーズ株式会社|スピーダ スター …

Sep 29, 2024 次世代型キメラ抗原受容体(CAR)配列作製技術「Eumbody System」をコア技術とする医薬品の研究・開発。 「Eumbody System」は、一本鎖抗体(scFv)ライブラリ …See details»

Optieum Biotechnologies Raises JPY 290 million ($ 2.6 million) in …

Sep 30, 2021 We are pleased to announce that Optieum Biotechnologies Inc. has raised JPY 290 million ($ 2.6 million) in seed round funding. The round was led by ANRI and the …See details»

オプティアム・バイオテクノロジーズ|STARTUP DB(スタート …

社名 オプティアム・バイオテクノロジーズ 設立日 2020.06.30 (5年目) 大学発 愛媛大学 住所 〒791-0204 愛媛県東温市志津川454See details»

Optieum Biotechnologies Stock Price, Funding, Valuation, Revenue ...

Optieumbio.com. Overview & Products; Financials; Alternatives & Competitors; Customers; Total Raised $2.6M. Investors Count 3. Funding, Valuation & Revenue. 1 Fundings. Optieum …See details»

Optieum Biotechnologies Raises JPY 290 million ($ 2.6 million)

Sep 30, 2021 www.optieumbio.com Optieum Biotechnologies Raises JPY 290 million ($ 2.6 million) in Seed Round Funding We are pleased to announce that Optieum Biotechnologies …See details»

Working at Optimum Bio Lab - Glassdoor

See what employees say it's like to work at Optimum Bio Lab. Salaries, reviews, and more - all posted by employees working at Optimum Bio Lab.See details»

linkstock.net © 2022. All rights reserved